Defective Tbx2-dependent patterning of the atrioventricular canal myocardium causes accessory pathway formation in mice

Journal of Clinical Investigation

Volumn 121, Issue 2, 2011, Pages 534-544

  Aanhaanen, Wim T J ^a   Boukens, Bastiaan J D ^a   Sizarov, Aleksander ^a   Wakker, Vincent ^a   De Gier De Vries, Corrie ^a   Van Ginneken, Antoni C ^a   Moorman, Antoon F M ^a   Coronel, Ruben ^a   Christoffels, Vincent M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 40; CONNEXIN 43; PROTEIN SUBUNIT; SODIUM CHANNEL; SODIUM CHANNEL NAV1.5; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TBX2; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL TISSUE; ARTICLE; ATRIOVENTRICULAR CANAL; BIRTH; CELL JUNCTION; CONDUCTANCE; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; ELECTRIC POTENTIAL; FETUS; GAP JUNCTION; HEART ATRIUM FIBRILLATION; HEART CONDUCTION; HEART MUSCLE; HEART PREEXCITATION; HEART VENTRICLE TACHYCARDIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUDDEN DEATH; WOLFF PARKINSON WHITE SYNDROME;

ACCESSORY ATRIOVENTRICULAR BUNDLE; ANIMALS; ATRIOVENTRICULAR NODE; CONNEXIN 43; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART CONDUCTION SYSTEM; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MORPHOGENESIS; MYOCARDIUM; PREGNANCY; T-BOX DOMAIN PROTEINS; WOLFF-PARKINSON-WHITE SYNDROME;

EID: 79551514806     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI44350     Document Type: Article

References (61)

1. Munger TM, et al. A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989. Circulation. 1993;87(3):866-873.
2. Packard JM, Graettinger JS, Graybiel A. Analysis of the electrocardiograms obtained from 1000 young healthy aviators; ten year follow-up. Circulation. 1954;10(3):384-400.
3. Centurion OA, Shimizu A, Isomoto S, Konoe A. Mechanisms for the genesis of paroxysmal atrial fibrillation in the Wolff Parkinson-White syndrome: intrinsic atrial muscle vulnerability vs. electrophysiological properties of the accessory pathway. Europace. 2008;10(3):294-302.
4. Basso C, Corrado D, Rossi L, Thiene G. Ventricular preexcitation in children and young adults: atrial myocarditis as a possible trigger of sudden death. Circulation. 2001;103(2):269-275.
5. Wood FC, Wolferth CC, Geckeler GD. Histologic demonstration of accessory muscular connections between auricle and ventricle in a case of short P-R interval and prolonged QRS complex. Am Heart J. 1943;25(4):454-462.
6. Hahurij ND, et al. Accessory atrioventricular myocardial connections in the developing human heart: relevance for perinatal supraventricular tachycardias. Circulation. 2008;117(22):2850-2858.
7. Stroud DM, et al. Abnormal conduction and morphology in the atrioventricular node of mice with atrioventricular canal-targeted deletion of Alk3/Bmpr1a receptor. Circulation. 2007;116(22):2535-2543.
8. Anderson RH, Ho SY, Gillette PC, Becker AE. Mahaim, Kent and abnormal atrioventricular conduction. Cardiovasc Res. 1996;31(4):480-491.
9. Kolditz DP, et al. Epicardium-derived cells in development of annulus fibrosis and persistence of accessory pathways. Circulation. 2008;117(12):1508-1517.
10. Tallini YN, et al. Imaging cellular signals in the heart in vivo: Cardiac expression of the high-signal Ca2+ indicator GCaMP2. Proc Natl Acad Sci U S A. 2006;103(12):4753-4758.
11. James TN. Sudden death in babies: new observations in the heart. Am J Cardiol. 1968;22(4):479-506.
12. McGuire MA, et al. Atrioventricular junctional tissue. Discrepancy between histological and electrophysiological characteristics. Circulation. 1996;94(3):571-577.
13. Yanni J, Boyett MR, Anderson RH, Dobrzynski H. The extent of the specialized atrioventricular ring tissues. Heart Rhythm. 2009;6(5):672-680.
14. Aanhaanen WT, et al. Developmental origin, growth, and three-dimensional architecture of the atrioventricular conduction axis of the mouse heart. Circ Res. 2010;107(6):728-736.
15. Ma L, Lu MF, Schwartz RJ, Martin JF. Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development. 2005;132(24):5601-5611. (Pubitemid 43125885)
16. Habets PEMH, et al. Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in the atrioventricular canal: implications for cardiac chamber formation. Genes Dev. 2002;16(10):1234-1246.
17. Harrelson Z, et al. Tbx2 is essential for patterning the atrioventricular canal and for morphogenesis of the outflow tract during heart development. Development. 2004;131(20):5041-5052.
18. Aanhaanen WT, et al. The Tbx2+ primary myocardium of the atrioventricular canal forms the atrioventricular node and the base of the left ventricle. Circ Res. 2009;104(1):1267.
19. Kokubo H, Tomita-Miyagawa S, Hamada Y, Saga Y. Hesr1 and Hesr2 regulate atrioventricular boundary formation in the developing heart through the repression of Tbx2. Development. 2007;134(4):747-755.
20. Rutenberg JB, Fischer A, Jia H, Gessler M, Zhong TP, Mercola M. Developmental patterning of the cardiac atrioventricular canal by Notch and Hairy-related transcription factors. Development. 2006;133(21):4381-4390.
21. Boogerd KJ, et al. Msx1 and Msx2 are functional interacting partners of T-box factors in the regulation of connexin 43. Cardiovasc Res. 2008;78(3):485-493.
22. Chen YH, Ishii M, Sucov HM, Maxson RE Jr. Msx1 and Msx2 are required for endothelial-mesenchymal transformation of the atrioventricular cushions and patterning of the atrioventricular myocardium. BMC Dev Biol. 2008;8:75.
23. Jay PY, et al. Nkx2-5 mutation causes anatomic hypoplasia of the cardiac conduction system. J Clin Invest. 2004;113(8):1130-1137.
24. Munshi NV, et al. Cx30.2 enhancer analysis identifies Gata4 as a novel regulator of atrioventricular delay. Development. 2009;136(15):2665-2674.
25. Moskowitz IPG, et al. The T-Box transcription factor Tbx5 is required for the patterning and maturation of the murine cardiac conduction system. Development. 2004;131(16):4107-4116.
26. Pashmforoush M, et al. Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell. 2004;117(3):373-386.
27. Christoffels VM, Smits GJ, Kispert A, Moorman AF. Development of the pacemaker tissues of the heart. Circ Res. 2010;106(2):240-254.
28. Kreuzberg MM, et al. Connexin30.2 containing gap junction channels decelerate impulse propagation through the atrioventricular node. Proc Natl Acad Sci U S A. 2006;103(15):5959-5964.
29. Wessels A, Markman MWM, Vermeulen JLM, Anderson RH, Moorman AFM, Lamers WH. The development of the atrioventricular junction in the human heart. Circ Res. 1996;78(1):110-117. (Pubitemid 26004127)
30. Nakamura T, Colbert MC, Robbins J. Neural crest cells retain multipotential characteristics in the developing valves and label the cardiac conduction system. Circ Res. 2006;98(12):1547-1554.
31. Snarr BS, Wirrig EE, Phelps AL, Trusk TC, Wessels A. A spatiotemporal evaluation of the contribution of the dorsal mesenchymal protrusion to cardiac development. Dev Dyn. 2007;236(5):1287-1294.
32. de Lange FJ, et al. Lineage and morphogenetic analysis of the cardiac valves. Circ Res. 2004;95(6):645-654.
33. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol. 2001;230(2):230-242.
34. Peters NS, Rowland E, Bennett JG, Green CR, Anderson RH, Severs NJ. The Wolff-Parkinson- White syndrome: the cellular substrate for conduction in the accessory atrioventricular pathway. Eur Heart J. 1994;15(7):981-987.
35. Arad M, et al. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation. 2003;107(22):2850-2856.
36. Wolf CM, et al. Reversibility of PRKAG2 glycogenstorage cardiomyopathy and electrophysiological manifestations. Circulation. 2008;117(2):144-154.
37. Sidhu JS, et al. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome. Circulation. 2005;111(1):21-29.
38. Gaussin V, et al. Alk3/Bmpr1a receptor is required for development of the atrioventricular canal into valves and annulus fibrosus. Circ Res. 2005;97(3):219-226.
39. Davies JK, et al. Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome. Am J Physiol Heart Circ Physiol. 2006;290(5):H1942-H1951.
40. Banerjee SK, et al. A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia. Biochem Biophys Res Commun. 2007;360(2):381-387.
41. Calkins H, et al. Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Abbreviated therapeutic approach to Wolff-Parkinson-White syndrome. Circulation. 1992;85(4):1337-1346.
42. OuYang W, Hemmings HC Jr. Isoform-selective effects of isoflurane on voltage-gated Na+ channels. Anesthesiology. 2007;107(1):91-98.
43. Basson CT. A molecular basis for Wolff-Parkinson-White syndrome. N Engl J Med. 2001;344(24):1861-1864.
44. Yamada M, Revelli JP, Eichele G, Barron M, Schwartz RJ. Expression of chick Tbx-2, Tbx-3, and Tbx-5 genes during early heart development: evidence for BMP2 induction of Tbx2. Dev Biol. 2000;228(1):95-105.
45. Christoffels VM, Hoogaars WMH, Tessari A, Clout DEW, Moorman AFM, Campione M. T-box transcription factor Tbx2 represses differentiation and formation of the cardiac chambers. Dev Dyn. 2004;229(4):763-770.
46. Singh R, et al. Tbx20 interacts with smads to confine tbx2 expression to the atrioventricular canal. Circ Res. 2009;105(5):442-452.
47. Chi NC, et al. Foxn4 directly regulates tbx2b expression and atrioventricular canal formation. Genes Dev. 2008;22(6):734-739.
48. Le GL, et al. A 8.26Mb deletion in 6q16 and a 4.95Mb deletion in 20p12 including JAG1 and BMP2 in a patient with Alagille syndrome and Wolff-Parkinson-White syndrome. Eur J Med Genet. 2008;51(6):651-657.
49. Lalani SR, et al. 20p12.3 microdeletion predisposes to Wolff-Parkinson-White syndrome with variable neurocognitive deficits. J Med Genet. 2009;46(3):168-175.
50. Yang Z, et al. LAMP2 microdeletions in patients with Danon disease. Circ Cardiovasc Genet. 2010;3(2):129-137.
51. Bui YK, Renella P, Martinez-Agosto JA, Verity A, Madikians A, Alejos JC. Danon disease with typical early-onset cardiomyopathy in a male: focus on a novel LAMP-2 mutation. Pediatr Transplant. 2008;12(2):246-250.
52. Gollob MH, et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med. 2001;344(24):1823-1831.
53. Wakker V, Brons JF, Aanhaanen WT, van Roon MA, Moorman AF, Christoffels VM. Generation of mice with a conditional null allele for Tbx2. Genesis. 2010;48(3):195-199.
54. Agah R, Frenkel PA, French BA, Michael LH, Overbeek PA, Schneider MD. Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest. 1997;100(1):169-179.
55. Danielian PS, Muccino D, Rowitch DH, Michael SK, McMahon AP. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr Biol. 1998;8(24):1323-1326.
56. Sizarov A, Anderson RH, Christoffels VM, Moorman AF. Three-dimensional and molecular analysis of the venous pole of the developing human heart. Circulation. 2010;122(8):798-807.
57. Moorman AFM, Houweling AC, de Boer PAJ, Christoffels VM. Sensitive nonradioactive detection of mRNA in tissue sections: novel application of the whole-mount in situ hybridization protocol. J Histochem Cytochem. 2001;49(1):1-8.
58. Mommersteeg MTM, et al. Molecular pathway for the localized formation of the sinoatrial node. Circ Res. 2007;100(3):354-362.
59. Hoogaars WM, et al. Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria. Genes Dev. 2007;21(9):1098-1112.
60. Kruzynska-Frejtag A, et al. Periostin is expressed within the developing teeth at the sites of epithelial-mesenchymal interaction. Dev Dyn. 2004;229(4):857-868.
61. Soufan AT, Ruijter JM, van den Hoff MJB, de Boer PAJ, Hagoort J, Moorman AFM. Three-dimensional reconstruction of gene expression patterns during cardiac development. Physiol Genomics. 2003;13(3):187-195.